Dose-Finding, Feasibility Study of Optison in Contrast Enhanced U/S for the Detection of Carotid Artery Disease
- First Posted Date
- 2011-07-15
- Last Posted Date
- 2014-05-02
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 21
- Registration Number
- NCT01394926
- Locations
- πΊπΈ
GE Healthcare, Princeton, New Jersey, United States
Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis
- First Posted Date
- 2011-06-20
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 304
- Registration Number
- NCT01376089
- Locations
- πΊπΈ
GE Healthcare, Princeton, New Jersey, United States
IMPROVE Critical Care Study (Pilot)
Not Applicable
Completed
- Conditions
- Sedated ICU Patients
- Interventions
- Device: "Sedation Trial Monitor" is the name of the device used.
- First Posted Date
- 2011-05-26
- Last Posted Date
- 2011-05-26
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 74
- Registration Number
- NCT01361230
- Locations
- π¬π§
Royal Infirmary Edinburgh (Great Britain) ward 118, Edinburgh, Scotland, United Kingdom
Evaluation of Orthopedic Knee Measurement Using Lunar iDXA
Not Applicable
Completed
- Conditions
- Hemi Knee ArthroplastyPatello-femoral Osteoarthritis
- Interventions
- Device: iDXA knee software
- First Posted Date
- 2011-05-06
- Last Posted Date
- 2017-06-22
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 36
- Registration Number
- NCT01348958
- Locations
- π³πΏ
CGM Research Trust - Princess Margaret Hospital, Cashmere, Christchurch, New Zealand
Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer
Not Applicable
Terminated
- Conditions
- Breast Cancer
- Interventions
- Device: CE-BMRIDevice: DE-CEDM
- First Posted Date
- 2011-02-24
- Last Posted Date
- 2019-04-10
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 224
- Registration Number
- NCT01303419
- Locations
- π§πͺ
AZ St-Jan Brugge AV, Brugge, Belgium
πΊπΈSeattle Cancer Care Alliance, Seattle, Washington, United States
π©πͺInstitut fur Radiologie, Charite, Berlin, Germany
Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Young Adult Subjects
- First Posted Date
- 2010-12-23
- Last Posted Date
- 2013-07-02
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 218
- Registration Number
- NCT01265394
- Locations
- πΊπΈ
GE Healthcare, Princeton, New Jersey, United States
Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure
Phase 2
Completed
- Conditions
- Chronic Renal InsufficiencyDiabete MellitusCongestive Heart Failure
- Interventions
- First Posted Date
- 2010-12-03
- Last Posted Date
- 2018-08-29
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 284
- Registration Number
- NCT01252810
- Locations
- πΊπΈ
GE Healthcare, Princeton, New Jersey, United States
NICU-TECH RM9L-RS Probe ME Feasibility Study
Terminated
- Conditions
- Neonates
- First Posted Date
- 2010-08-13
- Last Posted Date
- 2019-08-06
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 31
- Registration Number
- NCT01181596
- Locations
- πΊπΈ
UCSD Medical Center, San Diego, California, United States
GE-148-002: A Phase 2, Open-label, Single-Center Study to Assess GE-148 (18F) Injection PET Imaging to Detect Localized Prostate Cancer
- First Posted Date
- 2010-08-06
- Last Posted Date
- 2014-02-14
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 25
- Registration Number
- NCT01176513
- Locations
- πΊπΈ
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem Levels
- First Posted Date
- 2010-07-20
- Last Posted Date
- 2013-12-04
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 203
- Registration Number
- NCT01165554
- Locations
- πΊπΈ
GE Healthcare, Princeton, New Jersey, United States
Β© Copyright 2025. All Rights Reserved by MedPath